Saphenous Nerve Block After Tibial Plateau ORIF
Launched by STANFORD UNIVERSITY · Mar 17, 2020
Trial Information
Current as of September 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective a specific type of pain relief, called a saphenous nerve block, can be after surgery for a tibial plateau fracture. A tibial plateau fracture is a serious injury to the knee area that can cause a lot of pain. Usually, doctors don’t use nerve blocks for this type of surgery because they worry it might hide important pain signals that indicate a serious complication called compartment syndrome. However, researchers believe that the saphenous nerve block might help manage pain without masking those critical warning signs.
To take part in this study, participants must be at least 18 years old and have a tibial plateau fracture that requires surgery. They cannot have certain other serious injuries or conditions that would make it unsafe to receive a nerve block or participate in the study. Those who join can expect to receive the saphenous nerve block during their surgery and will be monitored for its effectiveness in managing pain afterward. This trial is important because it could help improve pain management strategies for patients recovering from this common but painful injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tibial plateau fracture presenting for ORIF
- • Age greater than or equal to 18 years
- Exclusion Criteria:
- • Other concomitant life-threatening injuries
- • History of chronic pain prior to tibial plateau ORIF
- • Age \<18 years old
- • Pregnancy
- • Any condition impairing patient's ability to consent to participation in study
- • Existing condition contraindicating a nerve block
- • Non-English Speaking
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials